Congenital stenosis of the inferior vena cava
disease diseaseOn this page
Also known as congenital stenosis of the inferior caval veincongenital stenosis of the IVC
Summary
Congenital stenosis of the inferior vena cava (MONDO:0020451) is a disease. A subtype of congenital anomaly of the inferior vena cava — broader associated-gene and molecular evidence is on the parent page (see Disease family below).
Clinical features
No curated clinical features (Orphanet) for this disease.
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | congenital stenosis of the inferior vena cava |
| Mondo ID | MONDO:0020451 |
| Orphanet | 99122 |
| SNOMED CT | 62335009 |
| UMLS | C0265934 |
| MedGen | 539594 |
| GARD | 0019663 |
| Is cancer (heuristic) | no |
Also known as: congenital stenosis of the inferior caval vein · congenital stenosis of the IVC
Disease family
Classification path: disease › human disease › disease by body system or component › cardiovascular disorder › vascular disorder › congenital anomaly of the inferior vena cava › congenital stenosis of the inferior vena cava
Related subtypes (5): right inferior vena cava connecting to left-sided atrium, persistent eustachian valve, azygos continuation of the inferior vena cava, inferior vena cava interruption, primary inferior vena cava aneurysm
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
No tiered GWAS variants or ClinVar records for this disease.
Genes & proteins
No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).
Function
No pathway enrichment — requires an associated-gene cohort.
Therapeutics
No druggable-target or therapeutic data for this disease’s cohort.
Clinical trials & evidence
Clinical trials
Clinical trials: 0.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.